Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma

References

• AlmeidaMRPérez-SayánsMSuárez-PeñarandaJMp27Kip1 expression as a prognostic marker for squamous cell carcinoma of the head and neckOncol Lett20151052675268226722226
   PubMedGoogle Scholar
• AllenCTClavijoPEVan WaesCChenZAnti-tumor immunity in head and neck cancer: understanding the evidence, how tumors escape and immunotherapeutic approachesCancers (Basel)2015742397241426690220
   PubMedGoogle Scholar
• KimJWRohJLParkYCytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinomaAnn Surg Oncol201522266266925149434
   PubMedGoogle Scholar
• SavagnerPEpithelial–mesenchymal transitions: from cell plasticity to concept elasticityCurr Top Dev Biol201511227330025733143
   PubMed Web of Science ®Google Scholar
• SmithATeknosTNPanQEpithelial to mesenchymal transition in head and neck squamous cell carcinomaOral Oncol201349428729223182398
   PubMed Web of Science ®Google Scholar
• ZhangWShiXPengYHIF-1alpha promotes epithelial–mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancerPLoS One2015106e129603
   PubMed Web of Science ®Google Scholar
• SakamotoKImanishiYTomitaTOverexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomyAnn Surg Oncol201219261261921913013
   PubMedGoogle Scholar
• NijkampMMSpanPNHoogsteenIJvan der KogelAJKaandersJHBussinkJExpression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patientsRadiother Oncol201199334434821684617
   PubMed Web of Science ®Google Scholar
• YoshidaRMoritaMShojiFClinical significance of SIP1 and E-cadherin in patients with esophageal squamous cell carcinomaAnn Surg Oncol20152282608261425564163
   PubMedGoogle Scholar
• XieCGWeiSMChenJMDown-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasionPLoS One201275e3785422662237
   PubMedGoogle Scholar
• WenCLChenKYChenCTChuangJGYangPCChowLPDevelopment of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarkerJ Proteomics201275133963397622634079
   PubMedGoogle Scholar
• PeinadoHOlmedaDCanoASnail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nat Rev Cancer20077641542817508028
   PubMed Web of Science ®Google Scholar
• FanCCWangTYChengYAExpression of E-cadherin, Twist, and P53 and their prognostic value in patients with oral squamous cell carcinomaJ Cancer Res Clin Oncol2013139101735174423990016
   PubMedGoogle Scholar
• BalasundaramPSinghMKDindaAKThakarAYadavRStudy of beta-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastasesDiagn Pathol2014914525047112
   PubMed Web of Science ®Google Scholar
• ChowVYuenAPLamKYA comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinomaJ Cancer Res Clin Oncol20011271596311206273
   PubMedGoogle Scholar
• ZhangPSunYMaLZEB1: at the crossroads of epithelial–mesenchymal transition, metastasis and therapy resistanceCell Cycle201514448148725607528
   PubMed Web of Science ®Google Scholar
• SchmalhoferOBrabletzSBrabletzTE-cadherin, beta-catenin, and ZEB1 in malignant progression of cancerCancer Metastasis Rev2009281−215116619153669
   PubMed Web of Science ®Google Scholar
• VandewalleCVan RoyFBerxGThe role of the ZEB family of transcription factors in development and diseaseCell Mol Life Sci200966577378719011757
   PubMed Web of Science ®Google Scholar
• Romero-PérezLLópez-GarcíaMÁDíaz-MartínJZEB1 over-expression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinomaMod Pathol201326111514152423743934
   PubMedGoogle Scholar
• MiyaharaSHamasakiMHamatakeDClinicopathological analysis of pleomorphic carcinoma of the lung: diffuse ZEB1 expression predicts poor survivalLung Cancer2015871394425479687
   PubMedGoogle Scholar
• PaekARLeeCHYouHJA role of zinc-finger protein 143 for cancer cell migration and invasion through ZEB1 and E-cadherin in colon cancer cellsMol Carcinog201453E161E16824009065
   PubMedGoogle Scholar
• ChafferCLMarjanovicNDLeeTPoised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicityCell20131541617423827675
   PubMed Web of Science ®Google Scholar
• DrakeJMStrohbehnGBairTBZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cellsMol Biol Cell20092082207221719225155
   PubMedGoogle Scholar
• WellnerUBrabletzTKeckTZEB1 in pancreatic cancerCancers (Basel)2010231617162824281177
   PubMedGoogle Scholar
• ZhouJTaoDXuQExpression of E-cadherin and vimentin in oral squamous cell carcinomaInt J Clin Exp Pathol201518331503154
   Google Scholar
• SobinLHGospodarowiczMKWitterkindCTNM classification of malignant tumors7th edNew YorkJohn Wiley & Sons2009
   Google Scholar
• RanJLinDLWuRFZEB1 promotes epithelial–mesenchymal transition in cervical cancer metastasisFertil Steril201510361606161425963537
   PubMedGoogle Scholar
• MockKPrecaBTBrummerTThe EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitorsOncotarget2015616143991441225973542
   PubMed Web of Science ®Google Scholar
• HoCMHuFWLeeSSZEB1 as an indicator of tumor recurrence for Areca Quid chewing-associated oral squamous cell carcinomasJ Oral Pathol Med201544969369825367287
   PubMedGoogle Scholar
• HaddadYChoiWMcConkeyDJDelta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma linesClin Cancer Res200915253254219147758
   PubMed Web of Science ®Google Scholar
• MehendirattaMSolomonMCBoazKGuddattuVMohindraAClinicopathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: an immunohis-tochemical studyJ Oral Maxillofac Pathol2014152217222
   Google Scholar
• BryneMBoysenMAlfsenCGThe invasive front of carcinomas. The most important area for tumour prognosis?Anticancer Res1998186B475747649891553
   PubMedGoogle Scholar
• PiffkoJBankfalviAOfnerDPrognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomasBr J Cancer19977510154315469166951
   PubMedGoogle Scholar
• MasudaRKijimaHImamuraNLaminin-5γ2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinomaBiomed Res201233530931723124251
   PubMed Web of Science ®Google Scholar
• WangCHuangHHuangZTumor budding correlates with poor prognosis and epithelial–mesenchymal transition in tongue squamous cell carcinomaJ Oral Pathol Med201140754555121481005
   PubMedGoogle Scholar
• SethiSMacoskaJChenWMolecular signature of epithelial–mesenchymal transition (EMT) in human prostate cancer bone metastasisAm J Transl Res201031909921139809
   PubMed Web of Science ®Google Scholar